NDC 11534-193 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate

Dextroamphetamine Saccharate 3.125 mg/1; Amphetamine Aspartate Monohydrate 3.125 mg/1; Dextroamphetamine Sulfate 3.125 mg/1; Amphetamine Sulfate 3.125 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC11534-193

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate
Generic name
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
Labeler
SUNRISE PHARMACEUTICAL, INC.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA209799
Marketed since
July 4, 2018
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (2)

Package NDCDescriptionSince
11534-193-01100 TABLET in 1 BOTTLE (11534-193-01)Jul 4, 2018
11534-193-031000 TABLET in 1 BOTTLE (11534-193-03)Jul 4, 2018

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products